CodeBreak 100: Phase I study of AMG 510, a novel KRAS(G12C) inhibitor, in patients (pts) with advanced solid tumors other than non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) Meeting Abstract
| Authors: | Hong, D. S.; Kuo, J.; Sacher, A. G.; Barlesi, F.; Besse, B.; Kuboki, Y.; Dy, G. K.; Dembla, V.; Krauss, J. C.; Burns, T. F.; Kim, J.; Henary, H.; Ngarmchamnanrith, G.; Li, B. T. |
| Abstract Title: | CodeBreak 100: Phase I study of AMG 510, a novel KRAS(G12C) inhibitor, in patients (pts) with advanced solid tumors other than non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 167s |
| Language: | English |
| ACCESSION: | WOS:000560368301407 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.3511 |
| Notes: | Meeting Abstract: 3511 -- Source: Wos |
